| The Roche Investor Relations team would like to invite you to the Roche Pharma Day that will take place in London on Monday, 11 September 2023, starting at 10:00 BST and finishing at 14:30 BST with a reception. The Roche Pharma Day will address the following topics:
Presenters include:
You will have the opportunity to meet senior management during the event. Meeting information: Date/Time (BST): Monday, 11 September 2023 10:00 Registration 10:30 Event starts 14:30 Event ends, followed by refreshments with Roche Management Team Venue etc.venues St Paul’s 200 Aldersgate London EC1A 4HD map Registration has closed, if you still want to register, please contact investor.relations@roche.com. The slides will be available for download at 9:30 BST on the day of the event. > click here For participants who join via the webinar, the event will be listen-only apart from the Q&A where written questions can be submitted via a chat function. Pre-registration is required, please register for the webinar here*. Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com . A replay of the event will be available via > ir.roche.com *privacy notice Best regards, | |
| Bruno Eschli Head of Investor Relations | Loren Kalm Head of Investor Relations North America |
| | |
| | |
| Roche Investor Relations | |
| Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com | Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com |
| Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com | Dr. Gerard Tobin Phone: +41 61 68-72942 e-mail: gerard.tobin@roche.com |
| | |
| Investor Relations North America | |
| Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com | |
get the latest news and updates to your inbox.